I agree that this site is using cookies. You can find further informations here.
X
Para, Michael
~ 200  results:
Search for persons X
?
1

Effect of SARS-CoV-2 IgG Seroconversion After Convalescent ..:

Pannu, Sonal R. ; Cardone, Michael ; Doraiswamy, Mohankumar...
CHEST Critical Care.  2 (2024)  2 - p. 100048 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A Phase 1/2 Randomized, Placebo-Controlled Trial of Romides..:

McMahon, Deborah K ; Zheng, Lu ; Cyktor, Joshua C...
The Journal of Infectious Diseases.  224 (2020)  4 - p. 648-656 , 2020
Link: https://doi.org/10.1093/..
 
?
3

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune..:

Riddler, Sharon A ; Para, Michael ; Benson, Constance A...
Clinical Infectious Diseases.  72 (2020)  11 - p. e815-e824 , 2020
Link: https://doi.org/10.1093/..
 
?
4

Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir ..:

Flamm, Jason A ; Vanig, Thanes ; Gathe, Joseph...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S427-S428 , 2017
Link: https://doi.org/10.1093/..
 
?
5

Impact of HLA Class I Alleles on Timing of HIV Rebound Afte..:

Park, You Jeong ; Etemad, Behzad ; Ahmed, Hayat...
Pathogens and Immunity.  2 (2017)  3 - p. 431 , 2017
Link: https://doi.org/10.20411..
 
?
6

Taking Control: The Efficacy and Durability of a Peer-Led U..:

Brashers, Dale E. ; Basinger, Erin D. ; Rintamaki, Lance S...
Health Communication.  32 (2016)  1 - p. 11-21 , 2016
Link: https://doi.org/10.1080/..
 
?
7

541HIV Rebound Kinetics and CD4+ T-Cell Loss after Treatmen..:

Li, Jonathan ; Aga, Evgenia ; Bosch, Ronald...
Open Forum Infectious Diseases.  1 (2014)  suppl_1 - p. S23-S23 , 2014
Link: https://doi.org/10.1093/..
 
?
8

No Evidence for Decay of the Latent Reservoir in HIV-1–Infe..:

Gandhi, Rajesh T. ; Bosch, Ronald J. ; Aga, Evgenia...
The Journal of Infectious Diseases.  201 (2010)  2 - p. 293-296 , 2010
Link: https://www.jstor.org/st..
 
?
9

No Evidence for Decay of the Latent Reservoir in HIV‐1–Infe..:

Gandhi, Rajesh T. ; Bosch, Ronald J. ; Aga, Evgenia...
The Journal of Infectious Diseases.  201 (2010)  2 - p. 293-296 , 2010
Link: https://doi.org/10.1086/..
 
?
10

Safety, Pharmacokinetics, and Antiviral Activity of HGS004,..:

Lalezari, Jacob ; Yadavalli, Gopal K. ; Para, Michael...
The Journal of Infectious Diseases.  197 (2008)  5 - p. 721-727 , 2008
Link: https://doi.org/10.1086/..
 
?
11

Safety, Pharmacokinetics, and Antiviral Activity of HGS004,..:

Lalezari, Jacob ; Yadavalli, Gopal K. ; Para, Michael...
The Journal of Infectious Diseases.  197 (2008)  5 - p. 721-727 , 2008
Link: https://www.jstor.org/st..
 
?
12

Population Pharmacokinetics of Delavirdine and N-Delavirdin..:

Smith, Patrick F ; DiCenzo, Robert ; Forrest, Alan...
Clinical Pharmacokinetics.  44 (2005)  1 - p. 99-109 , 2005
Link: https://doi.org/10.2165/..
 
?
13

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome ..:

Knudtson, Eric ; Para, Michael ; Boswell, Hillary.
Obstetrics & Gynecology.  101 (2003)  Supplement - p. 1094-1097 , 2003
Link: https://doi.org/10.1097/..
 
?
14

Concentration-targeted phase I trials of atevirdine mesylat..:

Morse, Gene D. ; Reichman, Richard C. ; Fischl, Margaret A....
Antiviral Research.  45 (2000)  1 - p. 47-58 , 2000
Link: https://doi.org/10.1016/..
 
?
15

The Relation between Baseline HIV Drug Resistance and Respo..:

DeGruttola, Victor ; Dix, Lynn ; D'Aquila, Richard...
Antiviral Therapy.  5 (2000)  1 - p. 41-48 , 2000
Link: https://doi.org/10.1177/..
 
1-15